MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 1975-1978

  Fong, K M ^a,b,c   Kida, Y ^a   Zimmerman, P V ^b   Smith, P J ^a,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Genotype; Loss of heterozygosity; Lung cancer; MYCL; Tumour progression

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER STAGING; CHROMOSOME 1P; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0030469818     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.662     Document Type: Article

References (44)

1. BERGH JC. (1990). Gene amplification in human lung cancer. The MYc family genes and other proto-oncogenes and growth factor genes. Am. Rev. Respir. Dis., 142, S20-S26.
2. BIECHE, I. CHAMPEME MH, MERLO G, LARSEN CJ, CALLAHAN R AND LIDEREAU R. (1990). Loss of heterozygosity of the L-myc oncogene in human breast tumors. Hum. Genet., 85, 101-105.
3. BORG A, ZHANG QX, OLSSON H AND WENNGREN E. (1992). Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Genes Chrom. Cancer. 5, 311-320.
4. CARON H, VANSLUIS P, DEKRAKER J, BOKKERINK J, EGELER M, LAUREYS G, SLATER R, WESTERVELD A, VOUTH PA AND VERSTEEG R. (1996). Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastomu. N. Engl. J. Med., 334, 225-230.
5. CHAMPEME MH, BIKCHE I, LATIL A, HACENE K AND LIDEREAU R. (1992). Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancer. Int. J. Cancer. 50, 6-9.
6. CHENEVIX-TRENCH G, SOUTHALL M AND KIDSON C. (1989). Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls. Br. J. Cancer. 60, 872-874.
7. CROSSEN PE, MORRISON MJ AND COLLS BM. (1994). Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma. Br. J. Cancer, 69, 759-761.
8. DAWSON-SAUNDERS B AND TRAPP RG. (1990). Basic and Clinical Statistics, pp. 124-141. Appleton & Lange: Norwalk, Conn.
9. DRACOPOLI NC, HARNETT P, BALE SJ, STANGER BZ, TUCKER MA, HOUSMAN DE AND KEFFORD RF. (1989). Loss of alleles from the distal short arm of chromosome I occurs late in melanoma tumour progression. Proc. Natl Acad. Sci. USA, 86, 4614-4618.
10. ENOMOTO H, OZAKI T, TAKAHASHI H, NOMURA N, TABATA S, TAKAHASHI H, OHNUMA N, TANABE M, IWAI J, YOSHIDA H MATSUNAGA T AND SAKIYAMA S. (1994). Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene, 9, 2785-2791.
11. FONG KM, ZIMMERMAN PV AND SMITH PJ. (1995). Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res, 55, 28-30.
12. GRUNDY PE, TELZEROH PE, BRESLOW N, MOKSNESS J. HUFF V AND PATERSON MC. (1994). Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res., 54, 2331-2333.
13. GUAN KL, JENKINS CW, LI Y, NICHOLS MA, WU XY, OKEEFE CL, MATERA AG AND XIONG Y. (1994). Growth suppression by p18, a p16(INK4/MTS1)- and p14(INK4b/MTS2)-related CDK6 inhibitor, correlates with wild-type prb function. Genes Devel., 8, 2939-2952.
14. GYAPAY G, MORISSETTE J, VIGNAL A, DIB C, FIZAMES C, MILLASSUAU P, MARC S, BERNARDI G, LATHROP M AND WEISENBACH J. (1994). The 1993 94 GeneThon human genetic linkage map. Nature Genet., 7, 246-339.
15. HOGGARD N, BRINTNELL B, HOWELL A, WEISSENBACH J AND VARLEY J. (1995). Allelic imbalance on chromosome 1 in human breast caancer. II. Microsatellile repeat analysis. Genes Chrom., 12, 24-31.
16. IKEDA I, ISHIZAKA Y, OCHIAI M, SAKAI R, ITABASHI M, ONDA M, SUGIMURA T AND NAGAO M. (1988). No correlation between L-myc restriction fragment length polymorphism and malignancy of human colorectal cancers. Jpn. J. Cancer Res., 79, 674-676.
17. ISHIZAKl K, KATO M, IKENAGA M, HONDA K, OZAWA K AND TOGUCHIDA J. (1990). Correlation of L-myc genotypes to metastasis of gastric cancer and breast cancer (letter). J. Natl Cancer Inst., 82, 238-239.
18. KAKEIHI Y AND YOSHIDA O. (1989). Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients. Int. J. Cancer, 43, 391-394.
19. KATO M, TOGUCHIDA J, HONDA K, SASAKI MS, IKENAGA M, SUGIMOTO M, YAMAGUCHI T, KOTOURA Y, YAMAMURO T AND ISHIZAKI K. (1990). Elevated frequency of a specific allele of the L-myc gene in male patients with bone and soft-tissue sarcomas. Int. J. Cancer, 45, 47-49.
20. KAWASHIMA K, NOMURA S, HIRAI H, FUKUSHI S, KARUBE T, TAKEUCHI K, NARUKE T AND NISHIMURA S. (1992). Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients. Int. J. Cancer. 50, 557-561.
21. KAWASHIMA K, SHIKAMA H, IMOTO K, IZAWA M. NARUKE T, OKABAYASHI K AND NISHIMURA S. (1988). Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs. Proc. Natl Acad. Sci. USA, 85, 2353-2356.
22. KAYE F, BATTEY J, NAU M, BROOKS B, SEIFTER E, DE GREVE J, BIRRER M, SAUSVILLE E AND MINNA J. (1988). Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing. Mol. Cell. Biol., 8, 186-195.
23. LAHTI JM, VALENTINE M, XIANG J, JONES B, AMANN J, GRENET J. RICHMOND G, LOOK AT AND KIDD VJ. ( 1994). Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genet., 7, 370-375.
24. LAURENT-PUIG P, OLSCHWANG S, DELATTRE O, REMVIKOS Y, ASSELAIN B, MELOT T. VALIDIRE P. MULERIS M. GIRODET J, SALMON RJ AND THOMAS G (1992). Survival and acquired genetic alterations in colorectal cancer. Gastroenterology, 102, 1136-1141.
25. LEISTER I, WHITH A, BRUDERLEIN S, CZIEPLUCH C, KANGWAN-PONG D. SCHLAG P AND SCHWAB M. (1990). Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res., 50, 7232-7235.
26. MAKELA TP, HELLSTEN E, VHSA J, AUITALO K AND PELTONEN L. (1992). An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32. Hum. Mol. Genet., 1, 217.
27. NACAI MA, YAMAMOTO L. SALAORNI S, PACHECO MM, BRENTANI MM, BARBOSA EM, BRENTANI RR, MAZOYER S, SMITH SA, PONDER B AND MULLIGAN LM. (1994). Detailed deletion mapping of chromosome segment 17q12 21 in sporadic breast tumours. Genes Chrom. Cancer, 11, 58-62.
28. NAU MM, BROOKS BJ, BATTEY J, SAUSVILLE E, GAZDAR AF, KIRSCH IR, MCBRIDE OW, BERTNESS V, HOLLIS GF AND MINNA JD. (1985). L-myc, a new myc-rerelated gene amplified and expressed in human small cell lung cancer. Nature, 318, 69-73.
29. SARANATH D, PANCHAL RG, NAIR R, MEHTA AR, SANGHAVI V AND DEO MG. (1990). Restriction fragment length polymorphism of the L-myc gene in oral cancer patients. Br. J. Cancer, 61, 530-533.
30. SATO S, NAKAMURA Y AND TSUCHIYA E. (1994). Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res., 54, 5652-5655.
31. SHIRAISHI M, NOGUCHI M, SHIMOSATO Y AND SHKIYA T. (1989). Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res., 49, 6474-6479.
32. SLEBOS RJ, EVERS SG, WAGHNAAR SS AND RODENHUIS S. (1989). Cellular protooncogenes are infrequently amplified in untreated non-small cell lung cancer. Br. J. Cancer, 59, 76-80.
33. STOLER A AND BOUK N. (1985). Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation. Proc. Natl Acad. Sci. USA, 82, 570-574.
34. TAMAI S, SUGIMURA H, CAPORASO NE, RESAU JH, TRUMP BF, WESTON A AND HARRIS CC. (1990). Restriction fragment length polymorphism analysis of the L-myc gene locus in a case control study of lung cancer. Int. J. Cancer, 46, 411-415.
35. TAYLOR JA, BELL DA AND NAGORNEY D. (1993). L-myc protooncogene alleles and susceptibility to hepatocellular carcinoma. Int. J. Cancer. 54, 927-930.
36. TEFRH T, BORRESEN AL, AAMDAL S AND BROGGER A. (1990). Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients. Br. J. Cancer, 61, 809-822.
37. TSUCHIYA E, NAKAMURA Y, WENG SY, NAKAGAWA K, TSUCHIYA S, SUGANO H AND KITAGAWA T. (1992). Allelotype of non-small cell lung carcinoma comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52, 2478-2481.
38. TSUTSUMI M, YOKOTA J, KAKIZOE T, KOISO K, SUGIMURA T AND THRADA M. (1989). Loss of heterozygosity on chromosomes 1p and 11p in sporadic pheochromocytoma. J. Natl Cancer Inst., 81, 367-370.
39. WEISS J, RUBINFELD B, POLAKIS PG, MCCORMICK F, CAVENEE WK AND ARDEN KC. (1994). The RAP1GA1 locus for human Rap1-GTPase activating protein 1 maps to chromosome 1p36.1 >p35. Cytogenet. Cell Genet., 66, 18-21.
40. WEITH A, MARTINSSON T, CZIEPLUCH C, BRUDERLEIN S, AMLER LC, BERTHOLD F AND SCHWAB M (1989). Neuroblastoma consensus deletion maps to 1p36.1 2. Genes Chrom. Cancer. 1, 159-166.
41. WESTON A, CAPORASO NH, PERRIN LS, SUGIMURA H, TAMAI S, KRONTIRIS TG, TRUMP BF, HOOVER RN AND HARRIS CC. (1992). Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. Env. Health Persp., 98, 61-67.
42. WESTON A, LING-CAWLEY HM, CAPORASO NH, BOWMAN ED, HOOVER RN, TRUMP BF AND HARRIS CC, (1994). Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human ling cancer. Carcinogenesis, 15, 583-587.
43. YOKOTA J, WADA M, YOSHIDA T, NOGUCHI M, TERASAKI T, SHIMOSATO Y. SUGIMURA T AND THRADA M. (1988). Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Oncogene, 2, 607-611.
44. YOUNG J, BUTTENSHAW R, BUTTERWORTH L, WARD M. SEARLE J, LEGGETT B AND CHENEVIX-TRENCH G. (1994). Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. Oncogene, 9, 1053-1056.